Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UltralifeULBI -0.26%68 EBITDA Margin % is 3.22% as of Mar. 2026, which is 65% below its 10-year median of 9.09. GuruFocus rates ULBI with a GF Score™ of 68/100 and a GF Value™ of $9.27 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 3,031 Industrial Products companies, Ultralife ranks worse than 82.28% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ultralife's EBITDA for the
three
months ended in Mar. 2026 was $1.5 Mil. Ultralife's Revenue for the
three
months ended in Mar. 2026 was $47.4 Mil. Therefore, Ultralife's EBITDA margin for the quarter that ended in Mar. 2026 was 3.22%.
Ultralife (NAS:ULBI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ultralife EBITDA Margin % Related Terms
Ultralife EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ultralife's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ULBI vs STI, NEOV, SKYX: EBITDA Margin % Comparison
For the Electrical Equipment & Parts subindustry, Ultralife's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultralife EBITDA Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Ultralife's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ultralife's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ultralife (ULBI) has a EBITDA Margin % of 3.22% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ultralife and its competitors. This is 65% below median its historical median of 9.09. According to the industry distribution chart, Ultralife ranks #2494 out of 3031 companies in the Industrial Products industry, placing it in the top 82.3%.
Is Ultralife's EBITDA Margin % too high?
Ultralife's current EBITDA Margin % of 3.22% is 65% below median its 10-year median of 9.09. The Industrial Products industry median EBITDA Margin % is 9.42. Ultralife's value of 3.22% is 65.8% below this industry median. Based on the distribution chart, Ultralife ranks #2494 out of 3031 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Ultralife has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ultralife's EBITDA Margin % compare to STI and NEOV?
According to the Industrial Products industry distribution chart, Ultralife ranks #2494 out of 3031 companies for EBITDA Margin %. This places Ultralife in the lower half of its industry. The industry median EBITDA Margin % is 9.42. Ultralife's value of 3.22% is 65.8% below this benchmark. While the company's 10-year median is 9.09 vs. the industry median of 9.42, Ultralife has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Industrial Products company?
The median EBITDA Margin % among Industrial Products companies is 9.42, based on 3,031 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultralife's current EBITDA Margin % of 3.22% is 65.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ultralife and its competitors. For the Industrial Products industry, the median EBITDA Margin % is 9.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultralife's current EBITDA Margin % is 3.22%, which is 65% below median its own 10-year median of 9.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultralife stock overvalued right now?
Based on GuruFocus' analysis, Ultralife (ULBI) is currently considered Possible Value Trap. The stock's GF Value™ is $9.27, compared to a current price of $5.66 — trading 38.9% below its estimated fair value. The current EBITDA Margin % is 3.22%, which is 65% below median its 10-year median of 9.09 and 65.8% below the Industrial Products industry median of 9.42. Ultralife's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ultralife (ULBI), the current EBITDA Margin % is 3.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ultralife (ULBI) Overvalued in 2026?
Based on GuruFocus' analysis, Ultralife stock appears to be undervalued.
The current stock price of $5.66 is trading 38.9% below its estimated GF Value™ of $9.27.
GuruFocus considers Ultralife to be Possible Value Trap.
Key valuation signals for ULBI:
EBITDA Margin %: 3.22% (65% below median its 10-year median of 9.09)
GF Value™: $9.27 vs. price of $5.66 (38.9% below fair value)
Industry Position: 65.8% below the Industrial Products median (#2494 of 3031)
No single metric tells the full story. See the ULBI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
68GF Score
Get the complete analysis for ULBI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ULBI has been successfully added to your 
